References
- Wells K., Steed D., Zajko A., Webster M. Recognition and treatment of arterial insufficiency from Cafergot. J Vasc Surg, 1986, 4: 8–15.
- McKieman T., Bock K., Leya F., Grassman E., Lewis B., Johnston S. A. Ergot induced peripheral vascular insufficiency: non-interventional treatment. Catheter Cardiovasc Diagn, 1994, 31: 211–4.
- Cameron E. A., French E. B. St Anthony’s fire rekindled: gangrene due to therapeutic doses of ergotamine. BMJ, 1960, 2: 28–30.
- Garcia G., Goff J., Hadro N., O’Donnell S., Greatorex P. Chronic ergot toxicity: a rare cause of lower extremity ischaemia. J Vasc Surg, 2000, 31: 1245–7.
- Mortier E., Pouchot J., Vinceneux P., Lalande M. Ergotism related to interaction between nelfinavir and ergotamin. Am J Med, 2001, 110: 594.
- Montero A., Giovannoni A. G., Tvrde P. L. Leg ischaemia in a patient recieving ritonavir and ergotamine. Ann Intern Med, 1999, 130: 329–30.
- Vila A., Mykietiuk A., Bonvehi P., Tempotiti E., Uruena A., Herrera F. Clinical ergotism induced by ritonavir. Scand J Infect Dis, 2001, 33: 788–9.
- Ghali R., De Lean J., Doubille Y., Noel H. P., Labbe R. Erythromycin associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischaemia of the lower extremities and associated ischaemic neuropathy. Ann Vasc Surg, 1993, 7: 291–6.
- Tribble M. A., Gregg C. R., Margolis D. M., Amirkhan R., Smith J. W. Fatal ergotism induced by an HIV protease inhibitor. Headache, 2002, 42 (7): 694–5.